Cargando…
Recent Developments in Novel Antidepressants Targeting α4β2-Nicotinic Acetylcholine Receptors: Miniperspective
[Image: see text] Nicotinic acetylcholine receptors (nAChRs) have been investigated for developing drugs that can potentially treat various central nervous system disorders. Considerable evidence supports the hypothesis that modulation of the cholinergic system through activation and/or desensitizat...
Autores principales: | Yu, Li-Fang, Zhang, Han-Kun, Caldarone, Barbara J., Eaton, J. Brek, Lukas, Ronald J., Kozikowski, Alan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207546/ https://www.ncbi.nlm.nih.gov/pubmed/24901260 http://dx.doi.org/10.1021/jm401937a |
Ejemplares similares
-
The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profile
por: Yu, Li-Fang, et al.
Publicado: (2014) -
Cocaine potently blocks neuronal α(3)β(4) nicotinic acetylcholine receptors in SH-SY5Y cells
por: Ma, Ze-gang, et al.
Publicado: (2019) -
Differential modulation of experimental autoimmune encephalomyelitis by α9*- and β2*-nicotinic acetylcholine receptors
por: Simard, Alain R., et al.
Publicado: (2013) -
Distinctive single-channel properties of α4β2-nicotinic acetylcholine receptor isoforms
por: Weltzin, Maegan M., et al.
Publicado: (2019) -
High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes
por: Kassner, Michelle, et al.
Publicado: (2022)